Effect of Streptozotocin-diabetes on the Functioning of the Sphingomyelin-signalling Pathway in Skeletal Muscles of the Rat

 

 Buy Article Permissions and Reprints

Abstract

Aims/hypothesis: Ceramide is the main second messenger in the sphingomyelin-transmembrane signalling pathway. The compound is likely to play a role in the induction of insulin resistance. The aim of the present study was to examine the effect of streptozotocin diabetes on the content and composition of ceramides and sphingomyelins and the activity of neutral Mg²⁺-dependent sphingomyelinase and acid sphingomyelinase in different types of skeletal muscle of the rat. Methods: The experiments were carried out on two groups of male Wistar rats weighing 250 - 280 g: controls and those treated with streptozotocin at a dose of 60 mg/kg. Determinations were performed on three types of skeletal muscle: the slow-twitch oxidative (soleus), fast-twitch oxidative-glycolytic (red section of the gastrocnemius) and fast-twitch glycolytic (white section of the same muscle). The content and composition of ceramide- and sphingomyelin-fatty acids were determined using gas-liquid chromatography. The activity of the enzymes was measured using N-[¹⁴CH₃]-sphingomyelin as the substrate. Results: Twelve different ceramides and sphingomyelins were identified and quantified in each muscle with regard to the fatty acid residue. The ratio of total content of ceramide-saturated fatty acids to the total content of ceramide-unsaturated fatty acids was more than two. In the case of sphingomyelin, the ratio was similar to ceramide in the soleus and much higher in both sections of the gastrocnemius. Treatment with streptozotocin increased the total content of ceramide-fatty acids by 78 % (p < 0.001) in the soleus, 27.5 % (p < 0.01) in the red and 36.9 % (p < 0.001) in the white section of the gastrocnemius. Concomitantly, the total content of sphingomyelin-fatty acids decreased by 43.8 %, 31.2 %, 24.8 % (p < 0.001 in each case) in the respective muscles. The activity of neutral Mg²⁺-dependent sphingomyelinase was elevated by 69.5 %, 105.9 % and 62.3 % in the soleus and red and white gastrocnemius, respectively (p < 0.001 for each muscle). The activity of acid sphingomyelinase was stable in the soleus and white gastrocnemius and decreased by 15.7 % (p < 0.01) in the red gastrocnemius. Conclusion/interpretation: The results obtained show that insulin deficiency results in elevation in the content of ceramide in skeletal muscles. This indicates that the hormone is involved in regulation of the activity of the sphingomyelin-signalling pathway in the muscles.

References

• 1 Ariano M A, Amstrong R B, Edgerton V R. Hindlimb muscle fibre population of five animals.  J Histochem Cytochem. 1979;  21 51-55
  PubMedGoogle Scholar
• 2 Begum N, Ragolia L. Effect of tumor necrosis factor-α on insulin action in cultured rat skeletal muscle cells.  Endocrinology. 1996;  137 2441-2446
  CrossrefPubMedGoogle Scholar
• 3 Begum N, Ragolia L, Srinivasan M. Effect of tumor necrosis factor-α on insulin-stimulated mitogen-activated protein kinase cascade in cultured rat skeletal muscle cells.  Eur J Biochem. 1996;  238 214-220
  CrossrefPubMedGoogle Scholar
• 4 Bradford N M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding.  Anal Biochem. 1976;  72 248-254
  CrossrefPubMedGoogle Scholar
• 5 Brindley D N, Wang C N, Mei J, Xu J, Hanna A N. Tumor necrosis factor-α and ceramides in insulin resistance.  Lipids. 1999;  34 S85-S88
  PubMedGoogle Scholar
• 6 Dobrzyń A, Górski J. Ceramides and sphingomyelins in skeletal muscles of the rat: content and composition. Effect of prolonged exercise.  Am J Physiol Endocrinol Metab. 2002;  282 E277-E285
  PubMedGoogle Scholar
• 7 Folch J, Lees M, Stanley G HS. A simple method for the isolation and purification of total lipids from animal tissues.  J Biol Chem. 1957;  226 497-509
  PubMedGoogle Scholar
• 8 Gómez-Muñoz A. Modulation of cell signalling by ceramides.  Biochim Biophys Acta. 1998;  1391 92-109
  PubMedGoogle Scholar
• 9 Grigsby R J, Dobrowsky R T. Inhibition of ceramide production reverses TNF-induced insulin resistance.  Biochem Biophys Res Commun. 2001;  287 1121-1124
  CrossrefPubMedGoogle Scholar
• 10 Hajduch E, Balendran A, Batty I H, Litherland G J, Blair A S, Downes C P, Hundal H S. Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells.  Diabetologia. 2001;  44 73-183
  PubMedGoogle Scholar
• 11 Hannun Y A, Luberto C. Ceramide in the eucariotic stress response.  Trends Cell Biol. 2000;  10 73-80
  CrossrefPubMedGoogle Scholar
• 12 Mahadevappa V G, Holub B J. Chromatographic analysis of phosphinositides and their breakdown products in activated blood platelets/neutrophils. In: Kuksis A Chromatography of Lipids in Biomedical Research and Clinical Diagnosis. Amsterdam, The Netherlands; Elsevier 1987: 225-265
  Google Scholar
• 13 Mathias S, Peña L A, Kolesnick R N. Signal transduction of stress via ceramide.  Biochem J. 1998;  335 465-480
  CrossrefPubMedGoogle Scholar
• 14 Morrison W R, Smith L M. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol.  J Lipid Res. 1964;  5 600-608
  PubMedGoogle Scholar
• 15 Pfeilschifter J, Huwiler A. Ceramides as key players in cellular response.  News Physiol Sci. 2000;  15 11-15
  PubMedGoogle Scholar
• 16 Prevati M, Bertolaso L, Tramarin M, Bertagnolo V, Capitani S. Low nanogram range quantitation of diglycerides and ceramide by high-performance liquid chromatography.  Anal Biochem. 1996;  233 108-114
  CrossrefPubMedGoogle Scholar
• 17 Riboni L, Viani P, Bassi R, Prinetti A, Tettamanti G. The role of sphingolipids in the process of signal transduction.  Prog Lipid Res. 1997;  36 153-195
  PubMedGoogle Scholar
• 18 Schissel S L, Schuchman E H, Wiliams K J, Tabas I. Zn²⁺-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene.  J Biol Chem. 1996;  271 18431-18436
  CrossrefPubMedGoogle Scholar
• 19 Schmitz-Peiffer C, Craig D L, Biden T J. ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate.  J Biol Chem. 1999;  274 24 202-24 210
  PubMedGoogle Scholar
• 20 Spence M W, Byers D M, Palmer F BStC, Cook H W. A new Zn²⁺-stimulated sphingomyelinase in fetal bovine serum.  J Biol Chem. 1989;  264 5358-5363
  PubMedGoogle Scholar
• 21 Sullivan T E, Amstrong R B. Rat locomotory muscle fiber activity during trotting and galloping.  J Appl Physiol Respir Environ Exercise Physiol. 1978;  44 358-363
  PubMedGoogle Scholar
• 22 Summers S A, Garza L A, Zhou H, Brinbaum M J. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and AKT kinase activity by ceramide.  Mol Cell Biol. 1998;  18 5457-5464
  PubMedGoogle Scholar
• 23 Tomiuk S, Zumbansen M, Stoffel W. Characterization and subcellular localization of Murine and human magnesium-dependent neutral sphingomyelinase.  J Biol Chem. 2000;  275 5710-5717
  CrossrefPubMedGoogle Scholar
• 24 Turinsky J, Bayly B P, O’Sullivan D M. 1,2-diacylglycerol and ceramide levels in rat skeletal muscle and liver in vivo. Studies with insulin, exercise, muscle denervation and vasopressin.  J Biol Chem. 1990;  265 7933-7938
  PubMedGoogle Scholar
• 25 Van der Vusse G J, Roeman T HM, Reneman R S. Assessment of fatty acids in dog left ventricular myocardium.  Biochim Biophys Acta. 1980;  617 347-352
  PubMedGoogle Scholar
• 26 Wang C N, O’Brien L, Brindley D N. Effects of cell-permeable ceramides and tumor necrosis factor-α on insulin signaling and glucose uptake in 3T3-L1 adipocytes.  Diabetologia. 1998;  47 24-31
  PubMedGoogle Scholar

Dr. J. Górski

Department of Physiology · Medical University of Białystok

15-230 Białystok · Poland ·

Phone: +48(85)7485585

Fax: +48(85)7485586

Email: gorski@amb.edu.pl